Co-Inhibition of tGLI1 and GP130 Using FDA-Approved Ketoconazole and Bazedoxifene Is Synergistic Against the Growth and Metastasis of HER2-Enriched and Triple-Negative Breast Cancers
Sara G. Manore(Wake Forest University), Hui‐Wen Lo(Wake Forest University)
Cited by 1